Latest News
-

Looking Past the Spin: Results from a Clinical Trial of Cysteamine
⏱️ 6 min read
Phase 2/3 clinical trial results prove inconclusive for Huntington's drug cysteamine.
-

A recycled drug gives us new insight in to HD
⏱️ 7 min read
An existing drug could give a boost to HD brain cells – but it may need more testing before it’s back in the clinic
-

Through the eyes of a friend: changes in mood and behavior in early HD
⏱️ 8 min read
Companions of HD gene carriers are more likely to notice psychological changes in presymptomatic HD.
-

A multiple sclerosis drug that works for Huntington's disease: the real deal or too good to be true?
⏱️ 8 min read
Fingolimod, a drug used in multiple sclerosis, prevents memory problems in HD mice. Would it work in patients?
-

Mapping the anatomy of HD: a whole-brain history
⏱️ 10 min read
A new book for researchers describes a century of HD anatomy and presents evidence that HD affects the whole brain.
-

Liftoff: First humans treated with gene silencing drugs for HD!
⏱️ 8 min read
Major Announcement: First HD patients treated with gene silencing drugs
-

HDBuzz primer: Clinical trial designs and phases
⏱️ 17 min read
HDBuzz untangles hope from hype in clinical trial announcements
-

A Few Bad Seeds: Using Brain Fluid to Grow Clumps in Brain Cells
⏱️ 7 min read
HD brain fluid makes brain cells grow clumps.
-

New tool to measure outcomes in Huntington’s Disease clinical trials
⏱️ 6 min read
A better tool for HD trials! New research shows innovative way to measure mutant Huntingtin outside the brain
-

Huge study reveals new 'genetic modifiers' of Huntington's disease
⏱️ 8 min read
GeM-HD identifies the first solid leads in the hunt for genetic variations that affect Huntington's disease onset
HDBuzz Trial Tracker
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
Previously featured
-
AMT-130 at Four Years: Hopeful Signs, Complex Controls
-
September 2026: This month in Huntington’s disease research
-
Studying Stutters: What 900,000 genomes teach us about growing DNA repeats
-
Highlighting Mental Health Disparities in Indigenous Communities Affected by Huntington’s Disease
-
Encouraging news from Skyhawk, as SKY-0515 Phase 1/2 data continues to hold promise
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
